GlassScriptPhysician profile
David B Schwartz
NPI 1700965589
$989.35
in general payments reported to CMS, 2019-2025
10 companies · $13.75 in 2025
The $13.75 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $19.79 · 2021: $174 · 2022: $434 · 2024: $51.40 · 2025: $13.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $65.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $65.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Somnomed INC. | $260.86 | 2022 | |
| Minerva Surgical, INC | $161.13 | 2019-2020 | |
| Inspire Medical Systems, INC. | $147.27 | 2022 | |
| Ultradent Products INC | $112.99 | 2021 | |
| Mitsui Chemicals, INC. | $103.33 | 2019 | |
| Straumann USA LLC | $81.59 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $60.51 | 2021 | |
| Hologic Sales and Service, LLC | $38.23 | 2019 | |
| Kerr Corporation | $13.74 | 2019 | |
| Biolase, INC. | $9.70 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.